1. Home
  2. LGND vs FRME Comparison

LGND vs FRME Comparison

Compare LGND & FRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • FRME
  • Stock Information
  • Founded
  • LGND 1987
  • FRME 1893
  • Country
  • LGND United States
  • FRME United States
  • Employees
  • LGND 68
  • FRME N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • FRME Major Banks
  • Sector
  • LGND Health Care
  • FRME Finance
  • Exchange
  • LGND Nasdaq
  • FRME Nasdaq
  • Market Cap
  • LGND 2.2B
  • FRME 2.3B
  • IPO Year
  • LGND 1992
  • FRME N/A
  • Fundamental
  • Price
  • LGND $147.40
  • FRME $37.60
  • Analyst Decision
  • LGND Strong Buy
  • FRME Buy
  • Analyst Count
  • LGND 8
  • FRME 4
  • Target Price
  • LGND $144.71
  • FRME $44.50
  • AVG Volume (30 Days)
  • LGND 139.7K
  • FRME 329.1K
  • Earning Date
  • LGND 08-05-2025
  • FRME 07-23-2025
  • Dividend Yield
  • LGND N/A
  • FRME 3.88%
  • EPS Growth
  • LGND N/A
  • FRME 23.41
  • EPS
  • LGND N/A
  • FRME 3.85
  • Revenue
  • LGND $181,488,000.00
  • FRME $638,723,000.00
  • Revenue This Year
  • LGND $18.41
  • FRME $14.80
  • Revenue Next Year
  • LGND $18.87
  • FRME $4.35
  • P/E Ratio
  • LGND N/A
  • FRME $9.65
  • Revenue Growth
  • LGND 53.40
  • FRME 6.22
  • 52 Week Low
  • LGND $81.74
  • FRME $33.13
  • 52 Week High
  • LGND $129.90
  • FRME $46.13
  • Technical
  • Relative Strength Index (RSI)
  • LGND 68.73
  • FRME 35.18
  • Support Level
  • LGND $132.21
  • FRME $36.90
  • Resistance Level
  • LGND $149.21
  • FRME $38.04
  • Average True Range (ATR)
  • LGND 5.37
  • FRME 0.99
  • MACD
  • LGND 0.53
  • FRME -0.41
  • Stochastic Oscillator
  • LGND 83.70
  • FRME 2.99

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About FRME First Merchants Corporation

First Merchants Corp, through its subsidiaries, provides its customers with financial services delivered locally by bankers. It offers personal banking, business banking, real estate mortgage lending, cash management services, brokerage, wealth management, and insurance. The company reports in only one segment which is community banking.

Share on Social Networks: